Filters
Cytological analysis of voided urine and vaginal fluid has good accuracy for detecting endometrial cancer in women with postmenopausal bleeding, as shown in the DETECT trial.
Individuals with hypertensive disorders of pregnancy (HDP) may be at increased risk of dementia, as suggested in a retrospective cohort study.
New drug applications approved by US FDA as of 1-15 September 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Current use of oral menopausal hormone therapy may increase the risk of venous thromboembolism (VTE) regardless of dosage and treatment duration compared with no use, according to a study.
A positive association exists between early pregnancy metabolomic signatures and child growth acceleration, a study has shown.
Menopausal symptoms are influenced by sociodemographic and behavioural factors—including ethnicity, education, income, smoking, obesity, and depression—highlighting the need for a personalized approach to care, according to a meta-analysis.
Treating iron-deficiency anaemia (IDA) in pregnancy with intravenous (IV) iron results in better maternal and neonatal outcomes when compared with oral iron, according to a meta-analysis.
Supplementation with Withania somnifera (ashwagandha) root extract appears to improve sleep quality, body composition, and menopausal symptoms in postmenopausal women, as shown in a study.
Intrauterine instillation of mepivacaine substantially reduces pain during intrauterine device (IUD) placement, according to the results of a randomized controlled trial.
Women with pre-eclampsia face a heightened risk of subsequent kidney disease within the first postpartum year when compared with those whose pregnancies are complicated by gestational hypertension, as shown in a retrospective study.
